Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ACARIX.ST
- Price
- 0.25
- Stock movement down
- -0.00 (-0.20%)
- Company name
- Acarix A/S
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 280.27M
- Ent value
- 259.48M
- Price/Sales
- 40.51
- Price/Book
- 7.28
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -43.28%
- 1 year return (CAGR)
- 4.18%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
DIVIDENDS
ACARIX.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 40.51 |
| Price to Book | 7.28 |
| EV to Sales | 37.50 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.12B |
| EPS (TTM) | -0.05 |
| FCF per share (TTM) | -0.04 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 6.92M |
| Gross profit (TTM) | 5.96M |
| Operating income (TTM) | -52.37M |
| Net income (TTM) | -52.44M |
| EPS (TTM) | -0.05 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 86.15% |
| Operating margin (TTM) | -756.92% |
| Profit margin (TTM) | -757.86% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 24.41M |
| Net receivables | 4.32M |
| Total current assets | 34.31M |
| Goodwill | 0.00 |
| Intangible assets | 7.28M |
| Property, plant and equipment | 0.00 |
| Total assets | 42.10M |
| Accounts payable | 1.23M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.62M |
| Total liabilities | 3.62M |
| Shareholder's equity | 38.48M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -48.13M |
| Capital expenditures (TTM) | 925.00K |
| Free cash flow (TTM) | -49.06M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -136.25% |
| Return on Assets | -124.54% |
| Return on Invested Capital | -136.25% |
| Cash Return on Invested Capital | -127.47% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.25 |
| Daily high | 0.25 |
| Daily low | 0.24 |
| Daily Volume | 915K |
| All-time high | 8.29 |
| 1y analyst estimate | 0.40 |
| Beta | -0.36 |
| EPS (TTM) | -0.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACARIX.ST | S&P500 | |
| Current price drop from All-time high | -96.99% | -0.89% |
| Highest price drop | -97.64% | -19.00% |
| Date of highest drop | 6 May 2025 | 8 Apr 2025 |
| Avg drop from high | -96.57% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 319 days | 89 days |
COMPANY DETAILS
Marketcap
280.27M
Marketcap category
Small-cap
Description
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Employees
8
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As December 2025 unfolds, the European markets are showing a mix of cautious optimism and strategic anticipation, with the pan-European STOXX Europe 600 Index posting modest gains amid hopes for inter...
December 12, 2025
As the European market navigates a mixed landscape with major stock indexes showing varied performance, investors are keeping a close eye on opportunities that may arise from current economic conditio...
November 4, 2025
As the pan-European STOXX Europe 600 Index remains steady, investors are closely watching interest rate policies and trade dynamics that continue to shape market sentiment. In this context, penny stoc...
October 2, 2025
Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics – Open demonstrating that the CADScor® System is a cost-e...
June 26, 2025
Acarix, a global leader in AI and acoustics-based cardiac diagnostics, has been awarded the 2025 Digital Innovation Award with an honorable mention for Innovation in Cardiac Imaging at the Global Card...
March 14, 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues to demonstrate exceptional progress in its pursuit of o...
February 13, 2025
Acarix, a pioneer in the development of groundbreaking acoustic-based cardiac diagnostic solutions, is proud to announce a new strategic partnership with Geo-Med, LLC, a renowned Service-Disabled Vete...
February 5, 2025